“The hepatitis C virus (HCV) chronically affects up to 150 million people worldwide. In the UK, an estimated0.5% of the populated are affected. If left untreated, the virus can lead to severe liver damage and sometimes liver cancer. In 2014, two drugs were approved that offer a more than 90% cure rate for HCV; However, the NHS this week have been accused of disobeying guidelines and rationing their use. Is this the fault of the NHS? Or a greater issue with company pricing for new-to-market drugs?”
Read more at The Canary:
The NHS is rationing a drug that could cure thousands of a life limiting disease
Featured image via Flickr / ANSES (image cropped)
The Science Writer 